Overview

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Study Hypothesis: Clinical staging without laparotomy/splenectomy is adequate for children and young adults with Hodgkin's disease who receive chemotherapy as a component of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
Children's Cancer Group
Treatments:
Bleomycin
Cyclophosphamide
Doxorubicin
Etoposide
Liposomal doxorubicin
Mitogens
Prednisone
Procarbazine
Vinblastine
Vincristine